Abstract Streptococcus pyogenes (Group A Streptococcus; GAS) is exquisitely adapted to
the human host, resulting in asymptomatic infection, pharyngitis, pyoderma, scarlet fever or …

Vaccine development and implementation decisions need to be guided by accurate and
robust burden of disease data. We developed an innovative systematic framework outlining …

Considering the lack of existing evidence on economic burden for diseases caused by
group A Streptococcus, we estimated the economic burden per episode for selected …

Abstract The World Health Organization published the preferred product characteristics for a
Group A Streptococcus (Strep A) vaccine in 2018. Based on these parameters for the age of …

Abstract Background Group A Streptococcus (GAS) causes superficial pharyngitis and skin
infections as well as serious autoimmune sequelae such as acute rheumatic fever (ARF) …

Methods We previously conducted a systematic review with the goal of including population-
based data published between 2005 and October 2014. We have now updated our review …

Abstract Group A Streptococcus (GAS), a major pathogen, causes various respiratory
diseases with substantial morbidity and mortality worldwide. In this study, we develop an …

Abstract Group A Streptococcus (GAS) is a major human pathogen responsible for
superficial infections through to life-threatening invasive disease and the autoimmune …

Streptococcus pyogenes, or group A Streptococcus (GAS), a gram-positive bacterium, is
implicated in a wide range of clinical manifestations and life-threatening diseases. One of …

Objective To determine the best timing for surgical intervention for adults with recurrent
tonsillitis (RT). Methods A Markov model was constructed using variables and ranges based …